| Type of grant |
Title |
Grantee |
Status |
| Senior Fellowship |
Training in mucosal immunity and the evaluation of KIR: HLA genes in HIV-1 clade C infection: key components to HIV vaccine design |
Photini Kiepiela |
Ongoing |
| Senior Fellowship |
Building research infrastructure and capacity to implement an HIV/STD prevention trial in post conflict Liberia |
Stephen Kennedy |
Ongoing |
| Senior Fellowship |
Evolution of neutralizing antibodies among acute to early HIV subtype C infected individuals in Botswana: one year longitudinal study |
Takafira Mduluza |
Ongoing |
| Senior Fellowship |
Evolution of HIV-1 ARV drug resistance mutations in the ART naïve during therapy; threshold frequency levels and linkage context associated with treatment failure in Uganda |
Jonathan Kayondo |
Ongoing |
| Senior Fellowship |
Evaluating antiretroviral drug resistance in HIV infected children in Africa |
Cissy Kityo |
Ongoing |
| Senior Fellowship |
Identifying and assessing the prevalence and potency of broadly neutralising antibodies in a cohort of non-B HIV chronically infected individuals in rural Uganda |
Harr Freeya Njai |
Ongoing |
| Senior Fellowship |
Frequency and determinants of dual infection with different strains of HIV-1 in low and high-risk populations in Uganda |
Nicaise Ndembi |
Completed |
| Senior Fellowship |
Development and evaluation of high throughput, cheap and reliable assays for monitoring HIV-1 and HIV-2 viral loads in ARV programmes and clinical trials in developing countries |
Abraham Alabi |
Completed |
| Senior Fellowship |
Preventing peri-partum transmission of HIV-1 in Africa: Truvada®-based alternatives to Single-Dose Nevirapine in the light of future treatment options |
Didier Koumavi Ekouevi |
Completed |
| Senior Fellowship |
A multi-site double-blind placebo controlled randomised clinical trial to prevent immune reconstitution inflammatory syndrome with non-steroid anti-inflammatory drugs |
Jean Nachega |
Ongoing |
| Senior Fellowship |
Career development and strengthening institutional capacity for clinical research in TB at the Faculty of Health Sciences in Brazzaville |
Sunny Okhaide Oyakhirome |
Ongoing |
| Senior Fellowship |
The risk of pulmonary tuberculosis associated with intestinal helminth infection among children at two tuberculosis vaccine trial sites in sub-Saharan Africa |
Mark Hatherill |
Ongoing |
| Senior Fellowship |
The effect of HIV co-infection on the immune response to Mycobacterium tuberculosis in the lung |
Wendy Burgers |
Ongoing |
| Senior Fellowship |
Immune reconstitution inflammatory syndrome (IRIS) in schistosomiasis patients undergoing HAART |
Pauline Mwinzi |
Ongoing |
| Senior Fellowship |
Human lung innate immune pathways regulating the stasis and killing of M. tuberculosis in a high burden setting |
Keertan Dheda |
Completed |
| Senior Fellowship |
The impact of rapid genotypic detection of multi-drug resistant tuberculosis on treatment outcome in a semi-rural region of South Africa |
Mark Nicol |
Ongoing |
| Senior Fellowship |
The burden of tuberculosis in eastern Sudan: Epidemiology and drug resistance patterns of Mycobacterium tuberculosis isolates |
Maowia Mukthar |
Completed |
| Senior Fellowship |
BCG-induced immune correlates of protection against tuberculosis |
Willem Hanekom |
Completed |
| Senior Fellowship |
Malaria baseline studies towards characterising and establishing a clinical trial site at Mutengene, South West Region of Cameroon |
Eric Akum Achidi |
Ongoing |
| Senior Fellowship |
A cluster-randomised controlled trial to assess the impact of combined strategies (impregnated bed nets plus home management of malaria oriented by Rapid Diagnosis Test) on severe malaria morbidity in children aged 6 to 59 months in Burkina Faso |
Alfred Tiono |
Ongoing |
| Senior Fellowship |
A randomised controlled trial of oral iron therapy for treatment of post-malaria iron-deficiency anaemia in Malawian children comparing immediate post-discharge versus delayed treatment on iron uptake and haematological response |
Kamija Phiri |
Ongoing |
| Senior Fellowship |
Assessment of functionality of antibodies that associate with protection from clinical malaria using the in vitro Plasmodium falciparum growth inhibition assay |
Daniel Dodoo |
Ongoing |
| Senior Fellowship |
Validation of new biomarkers for monitoring Plasmodium falciparum reduced susceptibility/tolerance or resistance to artemisinin derivatives and partner drugs in Nigeria |
Christian Happi |
Ongoing |
| Senior Fellowship |
Understanding the mechanisms underlying the difference in susceptibility to malaria in an area of hyperendemic malaria in Burkina Faso: The potential role of regulatory T cells |
Issa Nebie |
Completed |
| Senior Fellowship |
Evaluation and implementation of high throughput PCR-based method for diagnosis and measurement of Plasmodium falciparum parasitaemia in clinical trials |
Davis Nwakanma |
Completed |
| Senior Fellowship |
Safety of artemisinin derivatives-based combination therapy in children with uncomplicated malaria and population-based pharmacovigilance: a capacity strengthening proposal for pharmacovigilance of antimalarial drugs in Africa |
Ambrose Talisuna |
Completed |
| Senior Fellowship |
Implementation of Seasonal Intermittent Preventive Treatment with Community Participation in Senegal |
Badara Cisse |
Ongoing |
| Senior Fellowship |
Assessment of the Public Health Benefit of artemisinin based combination therapies for uncomplicated malaria treatment in Mali |
Abdoulaye Djimde |
Completed |
| Senior Fellowship |
Understanding the mechanism of piperaquine resistance |
Alexis Nzila |
Completed |
| Career Development |
Patterns of HIV1 specific CD8+ T call epitope recognition determining plasma viral load trajectory and set point following HIV1 infection |
Jennifer Serwanga |
Completed |
| Career Development |
Immunological investigation of the HIV-tuberculosis associated immune reconstitution |
Molebogeng Rangaka |
Completed |
| Career Development |
A double-blind, placebo controlled randomised trial of vitamin A supplementation for modulation of Mycobacterium tuberculosis immune responses in children aged 5-14 years with latent tuberculosis reconstitution |
Idefayo Adetifa |
Completed |
| Career Development |
Identification of Plasmodium falciparum parasite virulence markers for the evaluation of the impact of malaria control intervention according to the local parasite populations |
Eboumbou Moukoko |
Completed |
| Career Development |
Intensive safety monitoring of antimalarial and antiretroviral drugs in pregnancy |
Esperanca Sevene |
Ongoing |
| PhD |
The role of Human leukocyte antigen (HLA) and killer immunoglobulin-like receptor (KIR) in HIV-2 infection: a key component to HIV vaccine design and its evaluation in Africa |
Louis Marie Yindom |
Completed |
| PhD |
An assessment of the understanding of the informed consent process by participants in microbicide intervention trials in Zambia |
Bornwell Sikateyo |
Completed |
| PhD |
Reconstitution of TB antigen specific IFN-Û responses in TB-HIV co-infected participants |
Thuli Mthiyane |
Ongoing |
| PhD |
Anti tuberculosis-anti retroviral drugs induced Hepatotoxicity and interaction of these drugs at the level of CYP 450 metabolism |
Getnet Yimer Ali |
Ongoing |
| PhD |
Host immunogenetic factors involved in the susceptibility to malaria in sympatric ethnic groups (Dogon and Fulani) in Mali |
Charles Arama |
Completed |
| PhD |
Understanding the mechanism of resistance to lumefantrine by Plasmodium falciparum |
Leah Mwai |
Completed |
| PhD |
Investigating the effects of inactive CYP2C19 alleles on chlorproguanil pharmacokinetics in adults and in children with mild malaria following Lapdap® treatment |
Janha Ramatoulie |
Completed |
| MSc |
Masters in Reproductive and Sexual Health Research |
Alasan Jobe |
Completed |
| MSc |
MSc in public Health |
Sunny Oyakhirome |
Ongoing |
